| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 236.503.992 $ | +135.634.417 $ | +449,0 % | 20 | 87.046.178 $ | +87.046.178 $ | 5 | |||||
| CG Oncology, Inc. | CGON | → 0 | Neutral | 102.545.419 $ | +39.636.350 $ | +63,0 % | 1 | 62.909.069 $ | +62.909.069 $ | 1 | |
| Tango Therapeutics, Inc. | TNGX | → 0 | Neutral | 16.791.647 $ | +14.885.223 $ | +780,8 % | 1 | ||||
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 10.163.894 $ | +8.624.618 $ | +560,3 % | 1 | ||||
| Avalo Therapeutics, Inc. | AVTX | → 0 | Schwach | 8.568.074 $ | +7.417.765 $ | +644,8 % | 1 | ||||
| Revolution Medicines, Inc. | RVMD | → 0 | Schwach | 7.857.022 $ | +2.616.052 $ | +49,9 % | 1 | 5.240.970 $ | +5.240.970 $ | 1 | |
| Liquidia Corp | LQDA | → 0 | Neutral | 7.732.020 $ | +4.584.221 $ | +145,6 % | 1 | ||||
| Tyra Biosciences, Inc. | TYRA | → 0 | Schwach | 7.605.806 $ | +5.514.174 $ | +263,6 % | 1 | ||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 5.750.368 $ | -1.854.428 $ | -24,4 % | 1 | 7.604.796 $ | +7.604.796 $ | 1 | |
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 7.464.229 $ | +6.293.888 $ | +537,8 % | 1 | ||||
| AGIOS PHARMACEUTICALS, INC. | AGIO | → 0 | Neutral | 7.088.975 $ | +6.225.067 $ | +720,6 % | 1 | ||||
| Minerva Neurosciences, Inc. | NERV | → 0 | Neutral | 6.854.823 $ | +6.854.823 $ | 1 | |||||
| Century Therapeutics, Inc. | IPSC | → 0 | Neutral | 6.662.087 $ | +6.662.087 $ | 1 | |||||
| Seven Fleet Capital Management LP | → 0 | 6.295.200 $ | +6.295.200 $ | 1 | |||||||
| SOLENO THERAPEUTICS INC | SLNO | → 0 | 5.683.900 $ | -338.758 $ | -5,6 % | 1 | 6.022.658 $ | +6.022.658 $ | 1 | ||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 5.268.685 $ | +5.268.685 $ | 1 | ||||||
| EUPRAXIA PHARMACEUTICALS INC. | EPRX | → 0 | Stark | 5.136.889 $ | +5.136.889 $ | 1 | |||||
| CytomX Therapeutics, Inc. | CTMX | → 0 | Schwach | 5.101.371 $ | +4.893.066 $ | +2.349,0 % | 1 | ||||
| Compass Therapeutics, Inc. | CMPX | → 0 | Neutral | 4.975.446 $ | +1.921.275 $ | +62,9 % | 1 | ||||
| Pharvaris N.V. | PHVS | → 0 | Neutral | 4.879.651 $ | +3.343.910 $ | +217,7 % | 1 | ||||
| Abivax S.A. | ABVX | → 0 | Schwach | 4.793.840 $ | +2.973.432 $ | +163,3 % | 1 | ||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 4.553.331 $ | +3.949.563 $ | +654,2 % | 1 | ||||
| 236.503.992 $ | +135.634.417 $ | +449,0 % | 20 | 87.046.178 $ | +87.046.178 $ | 5 | |||||